CLS · Celestica Inc

Track CLS — free

$383.19 +10.10 (+2.71%)

Rebalance outlook locked

Market Cap

$42.24B

114.98M

Volume · Oct 2 850.32K Avg daily vol (3M) 2.51M

Up next

Next earnings call

Oct 27, 2026 Est · unconfirmed · in 4 wks

Latest filing: 10-Q

filed Jul 27, 2026

Q1 2026 earnings call transcript

call held Apr 28, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$15.59B

Trailing 12 months

Net income (TTM)

$1.12B

Trailing 12 months

Revenue growth YoY

+62.4%

Year over year

Operating margin

8.8%

Trailing 12 months

P / E (TTM)

37.6

Trailing earnings · reciprocal yield 2.7%

FCF yield

1.2%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$535.70M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+0.3%

Year over year · more shares

Price change (1Y)

+46.7%

Trailing year

Short interest

3.4%

Latest settlement · 1.6 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 16.4 · calm Equity put/call 0.57

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +13%

above

Price vs 50-day avg +13%

above

RSI (14) 62

neutral

MACD trend Positive

52-week position 58%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return +34%

trailing

6-month return +6%

trailing

YTD return +26%

this year

Relative strength −6%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $329 › 200d $330 — 200d above 50d

Institutional flow Accumulating

+12% holders QoQ · +179 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.36% of float · ▼ -3.2% MoM · 1.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

887 holders — near 3-yr high, broad support

Squeeze score 51

elevated · 0–100

Fundamentals

Excellent

Revenue growth +28%

Y/Y

Gross margin 12%

expanding

EPS growth +98%

Y/Y

Valuation P/E 38.3

below peers

Balance sheet $180.9M

net debt

Quant / Vol

risk profile

Very High

Volatility 78%

annualized · 1-yr

Max drawdown −41%

past year

ATR 5.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Jul 27, 2026

Q3 2026

Revenue (in billions) Initiated $5.25B – $5.55B

prior qtr $4.7B midpoint +14.9% QoQ

Adjusted operating margin (non-GAAP)* Non-GAAP Initiated at least 8.4%

Adjusted EPS (non-GAAP)* Non-GAAP Initiated $2.88 – $3.08

2026 Annual Outlook

Revenue Initiated $20.5B

prior FY $12.39B midpoint +65.4% Y/Y

Adjusted operating margin (non-GAAP)* Non-GAAP Initiated at least 8.4%

Adjusted EPS (non-GAAP)* Non-GAAP Initiated $11.30

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+13% Bullish

Price vs 50-day avg

+13% Bullish

RSI (14)

62 Neutral

MACD trend

Positive Bullish

52-week position

58% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $329 › 200d $330 — 200d above 50d

Institutional flow Accumulating

+12% holders QoQ · +179 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.36% of float · ▼ -3.2% MoM · 1.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

887 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $234 Now $373 · 58% Range high $472

vs 200-day avg +13% vs 50-day avg +13%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EPS (non-GAAP) non-GAAP	$2.54	Q2 2026 filing	—
Adjusted gross profit (non-GAAP) non-GAAP	$538.7M	three months ended June 30, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP GAAP gross profit $577.5M +$9.6M Employee SBC expense -$48.4M TRS FVAs: gains = Adjusted gross profit (non-GAAP) $538.7M
Adjusted net earnings (non-GAAP) non-GAAP	$295.4M	Three months ended June 30, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP GAAP net earnings $368.8M +$19.3M Employee SBC expense -$104.1M TRS FVAs: gains +$9.9M Amortization of intangible assets (excluding computer software) +$2.9M Restructuring and other charges (recoveries) -$0.7M Miscellaneous Expense (Income) -$0.7M Adjustments for taxes = Adjusted net earnings (non-GAAP) $295.4M
Adjusted operating earnings (adjusted EBIAT) (non-GAAP) non-GAAP	$386.3M	Three months ended June 30, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP GAAP earnings from operations $458.3M +$19.3M Employee SBC expense -$104.1M TRS FVAs: gains +$9.9M Amortization of intangible assets (excluding computer software) +$2.9M Restructuring and other charges (recoveries) = Adjusted operating earnings (adjusted EBIAT) (non-GAAP) $386.3M
Adjusted operating margin (non-GAAP) non-GAAP	8.2%	Q2 2026 filing	—
Adjusted SG&A (non-GAAP) non-GAAP	$104.1M	Three months ended June 30, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP GAAP SG&A $58.1M -$9.7M Employee SBC expense +$55.7M TRS FVAs: gains = Adjusted SG&A (non-GAAP) $104.1M
ATS segment income	$56.4M	Q2 2026 filing	—
ATS segment margin	6.3%	the three months ended June 30, 2026 filing	—
ATS segment revenue as a percentage of total revenue	19%	the three months ended June 30, 2026 filing	—
Cash cycle days	47	Q2 2026 filing	—
CCS segment income	$329.9M	Q2 2026 filing	—
CCS segment margin	8.7%	the three months ended June 30, 2026 filing	—
CCS segment revenue as a percentage of total revenue	81%	the three months ended June 30, 2026 filing	—
Days in A/R	63	Q2 2026 filing	—
Days in accounts payable (A/P)	-73	Q2 2026 filing	—
Days in cash deposits	-10	Q2 2026 filing	—
Days in inventory	67	Q2 2026 filing	—
Non-GAAP free cash flow non-GAAP	$147.1M	the three months ended June 30, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP GAAP cash provided by operations $410.9M -$263.8M Purchase of property, plant and equipment, net of sales proceeds = Free cash flow (non-GAAP) $147.1M

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Electronic Components — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
CLS Celestica Inc this stock	$42.24B	+26.2%	+28.5%	38.3	3.4%
APH Amphenol Corp /De/	$416.11B	—	+51.7%	84.6	0.6%
GLW Corning Inc /Ny	$135.01B	+83.2%	+19.1%	71.9	2.0%
MRAAF Murata Manufacturing Co., Ltd./ADR	$93.18B	+141.4%	—	—	0.1%
TEL TE Connectivity plc	$63.28B	-4.3%	+8.9%	21.4	2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

887

% held: 75.7%
Net QoQ: +4.0M sh
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

413

View

Short & Settlement

Short Interest Falling

Shares short

3.9M

Days to cover: 1.6d
Change: -127.2K sh

View

Short Volume

Short vol %

39%

As of: Oct 1, 2026

Short Total

View

Fails to Deliver

FTD shares

1.2K

Value: $430.1K
As of: Sep 14, 2026

View

Off-Exchange

Off-exchange %

51.2%

Week of: Aug 24, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Buy

Member

Cleo Fields

Amount: $15.0K–$50.0K
Traded: Nov 3, 2025

View

Financials

Revenue (FY)

$12.4B

Net income (FY): $832.5M
EPS diluted: $7.16

View

Buybacks

Authorized

shares 5.7M

Remaining: shares 5.5M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Sep 11, 2026
This year: 14

View

Proposed Sales

Value

$7.2M

Shares: 20.1K
Filed: Sep 23, 2026

View

Earnings & Events

Webcasts

Last webcast

Jul 28, 2026

View

Performance

	5D	20D	120D	MTD	YTD
CLS	-0.1%	+34.3%	+6.2%	+3.2%	+26.2%
SPY	-0.4%	-0.2%	+12.4%	+0.2%	+12.0%
vs SPY	+0.3%	+34.5%	-6.2%	+3.1%	+14.2%

Capital returns

Buyback program · as of Jun 30, 2026

Authorized

shares 5.70M

Spent (derived)

shares 200,000

Remaining

shares 5.50M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1030894 CUSIP 15101Q207 13F (30d) 21 filings 15 filers Visit website Investor relations

CLS · Celestica Inc

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns